Asian Journal of Pharmaceutical Research

Author(s): Bhushan P. Gayakwad, Shashikant D. Barhate, Mayur S. Jain

DOI: 10.5958/2231-5691.2017.00038.7

Views: 681 (pdf),       11799 (html)

Access: Open Access

Cite: Bhushan P. Gayakwad, Shashikant D. Barhate, Mayur S. Jain. Form Fill Seal Technology: A Brief Review. Asian J. Pharm. Res. 2017; 7(4): 244-246. doi: 10.5958/2231-5691.2017.00038.7

Author(s): Bhushan P. Gayakwad, Shashikant D. Barhate, Mayur S. Jain

DOI: 10.5958/2231-5691.2017.00039.9

Views: 159 (pdf),       6938 (html)

Access: Open Access

Cite: Bhushan P. Gayakwad, Shashikant D. Barhate, Mayur S. Jain. Citric Acid cross linked cellulose based Hydrogel for Drug Delivery. Asian J. Pharm. Res. 2017; 7(4): 247-255. doi: 10.5958/2231-5691.2017.00039.9

Author(s): Mayur S. Jain, Shashikant D. Barhate, Bhushan P. Gayakwad, Prafull P. Patil

DOI: 10.5958/2231-5691.2018.00019.9

Views: 24 (pdf),       3617 (html)

Access: Open Access

Cite: Mayur S. Jain, Shashikant D. Barhate, Bhushan P. Gayakwad, Prafull P. Patil. Olaparib is an inhibitor of poly (ADP-Ribose) polymerase (PARP) Enzymes: A Review. Asian J. Pharm. Res. 2018; 8(2): 110-112. doi: 10.5958/2231-5691.2018.00019.9

Author(s): Mr. Bhushan P. Gayakwad, . Shashikant D. Barhate, Prafull P. Patil, . Mayur S. Jain

DOI: 10.5958/2231-5691.2018.00009.6

Views: 14 (pdf),       3076 (html)

Access: Open Access

Cite: Mr. Bhushan P. Gayakwad, . Shashikant D. Barhate, Prafull P. Patil, . Mayur S. Jain. Comparative Study of Gatifloxacin and Sparfloxacin as Quinolone Antibiotics: An Overview. Asian J. Pharm. Res. 2018; 8(1): 44-46. doi: 10.5958/2231-5691.2018.00009.6

Author(s): Mayur S. Jain, Shashikant D. Barhate, Bhushan P. Gayakwad

DOI: 10.5958/2231-5691.2018.00041.2

Views: 9 (pdf),       2789 (html)

Access: Open Access

Cite: Mayur S. Jain, Shashikant D. Barhate, Bhushan P. Gayakwad. Calanolide A New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI): A Review. Asian J. Pharm. Res. 2018; 8(4): 241-242. doi: 10.5958/2231-5691.2018.00041.2

Author(s): Mayur S. Jain, Shashikant D. Barhate

DOI: 10.5958/2231-5691.2019.00034.0

Views: 15 (pdf),       2707 (html)

Access: Open Access

Cite: Mayur S. Jain, Shashikant D. Barhate. Tazarotene, commonly marketed as Tazorac, Avage, and Zorac is member of the acetylenic class of Retinoids: A Review. Asian J. Pharm. Res. 2019; 9(3):206-208. doi: 10.5958/2231-5691.2019.00034.0

Author(s): Mayur S. Jain, Shashikant D. Barhate

DOI: 10.5958/2231-5691.2019.00030.3

Views: 4 (pdf),       2540 (html)

Access: Open Access

Cite: Mayur S. Jain, Shashikant D. Barhate. Review on Perflutren, A Diagnostic Drug that is intended to be used for contrast enhancement during the indicated Echocardiographic procedures. Asian J. Pharm. Res. 2019; 9(3):190-192. doi: 10.5958/2231-5691.2019.00030.3

Author(s): Mayur S. Jain, Shashikant D. Barhate

DOI: 10.5958/2231-5691.2019.00042.X

Views: 13 (pdf),       2214 (html)

Access: Open Access

Cite: Mayur S. Jain, Shashikant D. Barhate. Review on-Mogamulizumab is a Humanized Monoclonal Antibody (mAb) directed against CC chemokine receptor 4 (CCR4) for the treatment of Mycosis Fungoides (MF). Asian J. Pharm. Res. 2019; 9(4):260-262. doi: 10.5958/2231-5691.2019.00042.X

Author(s): Mayur S. Jain, Shashikant D. Barhate

DOI: 10.5958/2231-5691.2020.00010.6

Views: 11 (pdf),       2090 (html)

Access: Open Access

Cite: Mayur S. Jain, Shashikant D. Barhate. Samarium Sm 153 lexidronam is a radioactive medication used to treat pain caused by cancer: A Review. Asian J. Pharm. Res. 2020; 10(1):48-51. doi: 10.5958/2231-5691.2020.00010.6

Author(s): Mayur S. Jain, Shashikant D. Barhate

DOI:

Views: 47 (pdf),       1976 (html)

Access: Open Access

Cite: Mayur S. Jain, Shashikant D. Barhate. Favipiravir has been investigated for the treatment of life-threatening pathogens such as Ebola virus, Lassa virus, and now COVID-19: A Review. 10.5958/2231-5691.2021.00008.3 doi:

Author(s): Mayur S. Jain, Shashikant D. Barhate, Rahul D. Shimpi

DOI: 10.52711/2231-5691.2022.00029

Views: 0 (pdf),       1150 (html)

Access: Closed Access

Cite: Mayur S. Jain, Shashikant D. Barhate, Rahul D. Shimpi. Mobocertinib is an Oral kinase inhibitor targeted against EGFR and used in the treatment of Non-small cell Lung cancer: A Review. Asian Journal of Pharmaceutical Research. 2022; 12(2):179-2. doi: 10.52711/2231-5691.2022.00029

Author(s): Rahul D. Shimpi, Shashikant D. Barhate, Mayur S. Jain

DOI: 10.52711/2231-5691.2023.00013

Views: 0 (pdf),       820 (html)

Access: Closed Access

Cite: Rahul D. Shimpi, Shashikant D. Barhate, Mayur S. Jain. Bempedoic acid a novel drug used for the treatment of Hyperlipidaemia: A Review. Asian Journal of Pharmaceutical Research. 2023; 13(1):68-0. doi: 10.52711/2231-5691.2023.00013

Author(s): Mayur S. Jain, Shailesh K. Koradia

DOI: 10.52711/2231-5691.2023.00012

Views: 0 (pdf),       645 (html)

Access: Closed Access

Cite: Mayur S. Jain, Shailesh K. Koradia. Phosphodiesterase-5 (PDE5) Inhibitors in the Treatment of Erectile Dysfunction: A Review. Asian Journal of Pharmaceutical Research. 2023; 13(1):63-7. doi: 10.52711/2231-5691.2023.00012